3,647 result(s) found
TAT Technologies Surges 54% YTD: Growth Opportunities And Risks Analyzed
https://seekingalpha.com/article/4722979-tat-technologies-surges-54-percent-ytd-growth-opportunities-and-risks-analyzed?source=feed_tag_israel
Sep 24, 2024 - TAT Technologies reported impressive Q2 earnings with revenues up 36% and adjusted EBITDA growing 69%. Find out why TATT stock is a Buy.
0
Roadzen says its insiders and major shareholders extend lock-up agreements for another year
https://seekingalpha.com/news/4152529-roadzen-says-its-insiders-and-major-shareholders-extend-lock-up-agreements-for-another-year?source=feed_tag_india
Sep 24, 2024 - Roadzen (RDZN) extends lock-up agreements for major shareholders and insiders till 2025, totaling over 56 million shares.
0
I'm Buying Up To 9% Yield For Recurring Income
https://seekingalpha.com/article/4722762-im-buying-up-to-9-percent-yield-for-recurring-income?source=feed
Sep 24, 2024 - Read more on two income-focused investment opportunities with strong financials and diverse income streams, offering attractive yields for investors.
0
Cooking up some community fun in Garden Grove
https://www.ocregister.com/2024/09/23/cooking-up-some-community-fun-in-garden-grove/
Sep 23, 2024 - The annual Chili Cook-off and Car Show was Saturday at Eastgate Park.
0
IDEAYA Biosciences up on positive interim data for its uveal melanoma treatment
https://seekingalpha.com/news/4151889-ideaya-biosciences-up-on-positive-interim-data-for-its-uveal-melanoma-treatment?source=feed_sector_healthcare
Sep 23, 2024 - IDEAYA Biosciences (IDYA) reports positive interim Phase 2 data for darovasertib in neoadjuvant uveal melanoma, with successful FDA meeting for...
0
Biohaven up 15% on troriluzole trial results for spinocerebellar ataxia
https://seekingalpha.com/news/4151866-biohaven-up-15-troriluzole-trial-results-spinocerebellar-ataxia?source=feed_sector_healthcare
Sep 23, 2024 - Biohaven stock surges 15% as troriluzole shows promising results in trial data for spinocerebellar ataxia treatment. Read more here.
0
August credit card data shows no signs of 'blowups' amid qualms over consumer
https://seekingalpha.com/news/4151657-august-credit-card-data-shows-no-signs-of-blowups?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Sep 22, 2024 - Credit card issuers, on average, reported solid metrics in August as net charge-offs declined and delinquencies moved up by only 2 basis points ,with no signs of 'blowups'
0
Billionaire Ken Griffin Just Sold 9.3 Million Shares of Nvidia and Bought This Other Artificial Intelligence (AI) Stock That's Headed to the S&P 500 Instead
https://www.fool.com/investing/2024/09/22/billionaire-ken-griffin-just-sold-93-million-share/?source=iedfolrf0000001
Sep 22, 2024 - Ken Griffin of Citadel offloaded his Nvidia position and bought up shares in an emerging data analytics software stock.
0
These 5 Dividend Stocks are Down 21% to 77%. Here's Why They're Worth Buying and Holding for at Least 5 Years.
https://www.fool.com/investing/2024/09/22/these-5-dividend-stocks-are-down-21-to-77-heres-wh/?source=iedfolrf0000001
Sep 22, 2024 - Patient investors may want to take a closer look at these five out-of-favor turnaround plays.
0
Buehler takes loss for Dodgers, but has strong moments against Rockies
https://www.ocregister.com/2024/09/21/buehler-takes-loss-but-has-strong-moments-against-rockies/
Sep 21, 2024 - He struck out 9, most since his return in May, but gave up 3 runs over first 2 innings.
0